# Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty

> **NCT02271399** · PHASE2 · COMPLETED · sponsor: **Hanyang University Seoul Hospital** · enrollment: 156 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** acetylsalicylic acid
- **DRUG:** rivaroxaban

## Key facts

- **NCT ID:** NCT02271399
- **Lead sponsor:** Hanyang University Seoul Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-01
- **Final completion:** 2016-02
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2016-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02271399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02271399, "Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT02271399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*